42 related articles for article (PubMed ID: 21539821)
1. Rapid detection of KIT mutations in core-binding factor acute myeloid leukemia using high-resolution melting analysis.
Fuster O; Barragán E; Bolufer P; Cervera J; Larráyoz MJ; Jiménez-Velasco A; Martínez-López J; Valencia A; Moscardó F; Sanz MA
J Mol Diagn; 2009 Sep; 11(5):458-63. PubMed ID: 19644024
[TBL] [Abstract][Full Text] [Related]
2. Rapid
Choate KA; Raack EJ; Mann PB; Jones EA; Winn RJ; Jennings MJ
Biol Methods Protoc; 2024; 9(1):bpae012. PubMed ID: 38566776
[TBL] [Abstract][Full Text] [Related]
3. Comparison of an Unlabeled Probe High-Resolution Melting Analysis Assay (HRMA) for Factor V Leiden 1691 G/A Mutation to a Fluorogenic 5' Nuclease PCR Hydrolysis Assay.
Han H; Lewis S
J Appl Lab Med; 2024 May; ():. PubMed ID: 38775465
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of lncRNA DLEU7-AS1 is a novel favorable prognostic factor in acute myeloid leukemia.
Wang CZ; Ma BB; Xu ZJ; Zhou JD; Zhang TJ; Chen Q; Yao DM; Lin J; Qian J; Sha S
Biosci Rep; 2022 May; 42(5):. PubMed ID: 35506368
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of lncRNA
Yang L; Zhou JD; Zhang TJ; Ma JC; Xiao GF; Chen Q; Deng ZQ; Lin J; Qian J; Yao DM
Cancer Manag Res; 2018; 10():4999-5007. PubMed ID: 30464600
[TBL] [Abstract][Full Text] [Related]
6.
Zhang TJ; Zhou JD; Zhang W; Lin J; Ma JC; Wen XM; Yuan Q; Li XX; Xu ZJ; Qian J
Clin Epigenetics; 2018; 10():47. PubMed ID: 29643943
[TBL] [Abstract][Full Text] [Related]
7. High bone marrow
Zhou JD; Ma JC; Zhang TJ; Li XX; Zhang W; Wu DH; Wen XM; Xu ZJ; Lin J; Qian J
Oncotarget; 2017 Nov; 8(54):91979-91989. PubMed ID: 29190891
[TBL] [Abstract][Full Text] [Related]
8.
Zhou JD; Yao DM; Li XX; Zhang TJ; Zhang W; Ma JC; Guo H; Deng ZQ; Lin J; Qian J
Oncotarget; 2017 Sep; 8(39):66087-66097. PubMed ID: 29029494
[TBL] [Abstract][Full Text] [Related]
9. Novel multiplex bead-based assay for detection of IDH1 and IDH2 mutations in myeloid malignancies.
Shivarov V; Ivanova M; Hadjiev E; Naumova E
PLoS One; 2013; 8(9):e76944. PubMed ID: 24098815
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of isocitrate dehydrogenase in acute lymphoblastic leukemia.
Zhang Y; Wei H; Tang K; Lin D; Zhang C; Mi Y; Wang L; Wang C; Wang M; Wang J
Genet Test Mol Biomarkers; 2012 Aug; 16(8):991-5. PubMed ID: 22809434
[TBL] [Abstract][Full Text] [Related]
11. Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients.
Chotirat S; Thongnoppakhun W; Promsuwicha O; Boonthimat C; Auewarakul CU
J Hematol Oncol; 2012 Mar; 5():5. PubMed ID: 22397365
[TBL] [Abstract][Full Text] [Related]
12. IDH mutations in glioma and acute myeloid leukemia.
Dang L; Jin S; Su SM
Trends Mol Med; 2010 Sep; 16(9):387-97. PubMed ID: 20692206
[TBL] [Abstract][Full Text] [Related]
13. Comparison of immunohistochemistry, DNA sequencing and allele-specific PCR for the detection of IDH1 mutations in gliomas.
Loussouarn D; Le Loupp AG; Frenel JS; Leclair F; Von Deimling A; Aumont M; Martin S; Campone M; Denis MG
Int J Oncol; 2012 Jun; 40(6):2058-62. PubMed ID: 22447191
[TBL] [Abstract][Full Text] [Related]
14. Development of high-resolution melting analysis for the detection of the MYD88 L265P mutation.
Wang CZ; Lin J; Qian J; Shao R; Xue D; Qian W; Xiao GF; Deng ZQ; Yang J; Li Y; Chen XX
Clin Biochem; 2013 Mar; 46(4-5):385-7. PubMed ID: 23178471
[TBL] [Abstract][Full Text] [Related]
15. Isocitrate dehydrogenase mutations in myeloid malignancies.
Medeiros BC; Fathi AT; DiNardo CD; Pollyea DA; Chan SM; Swords R
Leukemia; 2017 Feb; 31(2):272-281. PubMed ID: 27721426
[TBL] [Abstract][Full Text] [Related]
16. Rapid and reliable detection of IDH1 R132 mutations in acute myeloid leukemia using high-resolution melting curve analysis.
Lin J; Qian J; Yao DM; Li Y; Yang J; Chen Q; Chai HY; Xiao GF; Xu WR
Clin Biochem; 2011 Jul; 44(10-11):779-83. PubMed ID: 21539821
[TBL] [Abstract][Full Text] [Related]
17. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.
Wagner K; Damm F; Göhring G; Görlich K; Heuser M; Schäfer I; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar AA; Fiedler W; Kirchner HH; Brugger W; Zucknick M; Schlegelberger B; Heil G; Ganser A; Krauter J
J Clin Oncol; 2010 May; 28(14):2356-64. PubMed ID: 20368538
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
